Domicilium Real Estate Fund III LP (ELOX) swaps 1.25M shares for pre-funded warrants
Rhea-AI Filing Summary
Domicilium Real Estate Fund III LP, a ten percent owner of Eloxx Pharmaceuticals, Inc., reported a restructuring of its position rather than an open-market trade. According to the filing, the Fund exchanged 1,250,000 shares of Eloxx common stock for pre-funded warrants to purchase an equivalent number of common shares.
Footnotes explain that all share amounts reflect an 11-for-1 reverse stock split effective May 29, 2026. After this adjustment, the Fund reports holding 238,422 pre-funded warrants directly and 14,285 shares of common stock indirectly through related entities. The pre-funded warrants have a $0.0000 exercise price, no expiration date, and include a 4.99% cap that prevents exercises if the holder would beneficially own more than 4.99% of outstanding common shares immediately after exercise.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Pre-funded Warrant | 113,636 | $0.00 | -- |
| Other | Common Stock, $0.01 par value per share | 113,636 | $0.00 | -- |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Common Stock, $0.01 par value per share | -- | -- | -- |
Footnotes (1)
- Pursuant to the terms of the pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants"), Domicilium Real Estate Fund III LP (the "Fund"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer. These securities reflect a 11 for 1 reverse stock split effective May 29, 2026. The securities are owned directly by the Fund and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (iii) Daniel Simon, the managing member of Domicilium and the General Partner. The securities are owned by various entities and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to such entities and (ii) Daniel Simon, the managing member of Domicilium. The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.